Clinical trial · Observational
Tissue Eosinophils in Non-Small Cell Lung Cancer (the TEN Study)
NCT05537701CI-TRIAL-00072998TENactive not recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The primary objective is to describe eosinophil infiltration in resected (early stage) NSCLC. Secondary objectives are: * to investigate the correlation of T-Eos and B-Eos in the aforementioned patient population; * to investigate the correlation between T-Eos and overall \& disease-free survival; * to investigate the localization of T-Eos (periphery vs. center of the tumor lesions).
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Non-small Cell Lung Cancer | Lung Non-Small Cell Carcinoma | ALIAS | 0.90 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Percentage of tumor associated tissue eosinophilia by immunohistochemistry and computerised quantification
- timeFrame
- October 2022
Secondary outcomes (3)
- measure
- to investigate the correlation of tissue (T)-Eos and blood (B)-Eos in the aforementioned patient population
- timeFrame
- December 2022
- description
- Tissue and blood eosinophil correlation
- measure
- to investigate the correlation between T-Eos and overall & disease-free survival
- timeFrame
- December 2022
- description
- overall and disease-free survival
- measure
- to investigate the localization of T-Eos (periphery vs. center of the tumor lesions)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Resected, early stage NSCLC between 01-01-2015 and 30-04-2022 with available tumour tissue Exclusion Criteria: * Inclusion in a clinical study contraindicating enrollment in the present study
References
Publications (0)
Data not yet available
No reference posted for this study.